Long Covid, Post Covid Syndrome and H.E.L.P. Apheresis
More than 3.5 million people have been diagnosed with Covid-19 in Germany to date and are considered to have recovered. But one in ten, or about 350,000 people, continue to suffer from various late effects such as extreme fatigue, breathing difficulties, chest and joint pain, odor disorders and persistent fatigue (CFS: chronic fatigue syndrome). One in five people also experience psychological symptoms such as anxiety, depressed mood and sleep disturbance after a corona infection. About 50 different symptoms are now described.
Dr. med. Beate R. Jaeger addresses this clinical picture and proposes the extracorporeal procedure for Long Covid therapy – especially to preserve the microcirculation of the lungs. Dr. Jaeger points out that the importance of H.E.L.P. -Apheresis for COVID-19 therapy actually owes much to the observations of pathologists, namely because they described generalized endotheliitis in COVID-19:
“Viruses have already been detected in the alveolar epithelium and endothelial cells of deceased COVID-19 patients. They show a picture of simultaneous massive inflammatory and procoagulant activation with cell necrosis, thrombi, and massive fibrinoid deposits in the lung microcirculation. These fibrin deposits agglutinate the lung tissue and massively impede gas exchange.” In other words, H.E.L.P. -Apheresis can be used as a promising therapeutic approach for long covid syndrome due to its anti-inflammatory and anticoagulant effects.
Who is affected by post covid?
Long covid or post covid syndrome can occur in all age groups (from children to adults). Regardless of the severity of the corona infection – from asymptomatic to severe – long covid can severely impact patients’ quality of life over a long period of time.
Dr. Jaeger’s goal is to increase public acceptance and awareness of Long Covid, initiate treatment approaches and research on the topic, and help Long Covid patients regain quality of life.
In recent months, Dr. Beate R. Jaeger has treated well over 100 patients with severe Long Covid symptoms with H.E.L.P. -Apheresis. The good therapy results so far will soon be available as a study.